PODCAST · business
Rx for Biotech
by Podcast Host Chris Leidli
"Rx for Biotech" is a healthcare education podcast dedicated to helping patients, caregivers, and healthcare professionals understand the rapidly evolving world of advanced therapies - and how patients can access them. From cell therapies and gene therapies to radiopharmaceuticals, immunotherapies, and next-generation treatments for cancer and autoimmune disease, this channel bridges the gap between breakthrough science and real-world patient care. Hosted by Chris Leidli, founder of Genoplex and longtime host of the Rx for Biotech podcast, each episode features conversations with:• Biotech and pharmaceutical CEOs• Physician leaders and researchers• AI and tech leaders building tools to improve healthcare access• Innovators building the next generation of personalized therapiesAbout Therapy4me.aiTherapy4me.ai is a consumer education and care-navigation platform designed to help patients find and connect with specialists at treatment centers offering personalized medicines and ad
Episodes
-
What If It’s Not Just Stress? Hormones, Menopause & Women’s Health with Sharon Lemoine, ARNP
What if your fatigue, anxiety, weight gain, poor sleep, low libido, or brain fog are not “just stress”? Too many women are told they are stressed, anxious, depressed, or “just getting older” when their symptoms may deserve a deeper look. In this episode of Rx for Biotech, host Chris Leidli sits...
-
How Cancer Uses an “Invisibility Cloak” - And How Kazia Therapeutics Is Trying to Remove It
We all know that cancer is caused by the rapid growth of tumor cells - but the ability for cancer to hide from the immune system is also a big challenge that scientists face when designing new therapies. In this episode of Rx for Biotech, host Chris Leidli speaks with John Friend, MD, CEO of…
more -
Synthetic Lethality Explained: Targeting Cancer’s DNA Repair Weaknesses
Can precision oncology help identify cancer’s genetic weaknesses and turn them into therapeutic opportunities? In this episode of "Rx for Biotech", host Chris Leidli speaks with Oren Gilad, CEO of Aprea Therapeutics, about the rapidly evolving field of synthetic lethality, DNA damage response…
more -
Can T-Cell Engagers Crack Solid Tumors? The Next Frontier in Cancer Immunotherapy
Can we teach the immune system to attack solid tumors more effectively - and potentially create longer-lasting responses for cancer patients? In this episode of Rx for Biotech, host Chris Leidli sits down with Jack Silberstein, Founder and CEO of Deck Bio, to explore the next generation of cancer...
-
Your Doctor Might Have Missed It - How AI Is Giving Cancer Patients a Second Opinion
Can artificial intelligence help cancer patients understand their diagnosis, find more personalized treatment options, and become better advocates for their own care? In this episode of Rx for Biotech, I met with Steve Brown, Founder and CEO of CureWise, an AI-powered patient advocacy platform...
-
Can Stem Cell Therapy Heal Chronic Back Pain? The Future of Regenerative Medicine
Can stem cell therapy help repair damaged spinal discs instead of simply masking pain? Millions of people suffer from chronic low back pain and degenerative disc disease, yet today's standard treatments often focus on symptom management through pain medications, steroid injections, or invasive...
-
Part 2: What Is Radioligand Therapy? A New Precision Treatment for Cancer Explained
What if cancer treatment could find and destroy cancer cells with extraordinary precision while minimizing damage to healthy tissue? In Part 2 of this special Rx for Biotech series, Dr. Babak Saboury and Dr. Eliot Siegel from United Theranostics explain radioligand therapy (RLT), one of the...
-
Part 1: The Radiopharmaceutical Launch Playbook: What Pharma Must Get Right Beyond the Drug
What does it really take to successfully launch a radiopharmaceutical? In Part 1 of this special roundtable “Rx for Biotech” podcast series, Chris Leidli met with Dr. Babak Saboury and Dr. Eliot Siegel, founders of United Theranostics and nationally recognized leaders in nuclear oncology, to...
-
Why Fertility Care Needs to Change - And How Technology Can Help
What if AI could help women better understand their bodies and take control of their health before problems become crises? In this episode of #RxforBiotech, host Chris Leidli sits down with Kirsten Karchmer, Founder and CEO of Conceivable, to discuss the future of women's health, fertility…
more -
The Future of Multiple Sclerosis Treatment: New Hope for MS Patients | Jason Tardio, Immunic
What if the future of multiple sclerosis treatment could go beyond suppressing inflammation - and actually help protect the brain? In this episode of Rx for Biotech, host Chris Leidli sits down with Jason Tardio, President & COO of Immunic Therapeutics, to discuss the evolving future of treatment...
-
What If Your Own Cells Could Cure Cancer? CAR-T Therapy Explained
What if your own immune cells could be engineered to fight and even cure cancer? In this episode of Rx for Biotech, host Chris Leidli sits down with Navneet Majhail, MD, a leading expert in blood cancers, bone marrow transplants, and CAR-T cell therapy, to break down one of the most powerful...
-
The Future of Brain Cancer Care: Combining Diagnostics and Targeted Radiation Therapy
Why is brain cancer so hard to detect and treat - and what if we could change that? In this episode of Rx for Biotech, host Chris Leidli sits down with Marc Hedrick, CEO of Plus Therapeutics, and Russell Bradley, General Manager of CNSide Diagnostics, to explore a new, integrated approach to...
-
How Ossium Health is Changing Stem Cell Therapy and Regenerative Medicine
What if you could get a Transplant and Reset your Immune System in less than 48 Hours? In this episode of Rx for Biotech, host Chris Leidli sits down with Kevin Caldwell, CEO of Ossium Health, to explore how bone marrow transplants, cell therapy, and bioengineered immune systems are transforming...
-
How Targeted Chemotherapy and Immunotherapy are Changing Cancer Care
What if chemotherapy could target tumors without harming the rest of the body? In this episode of *Rx for Biotech*, host Chris Leidli sits down with Christina Coughlin, MD, PhD, CEO of Avacta Therapeutics, to explore a new approach to cancer treatment using targeted chemotherapy and precision...
-
The Future of Precision Medicine: How Biomarkers Can Guide Your Treatment
What if a simple blood test could reveal how your body responds to disease - or even help doctors choose the right treatment for you? In this episode of Rx for Biotech, host Chris Leidli speaks with Mo Jain, MD, PhD, co-founder of Sapient, about how scientists are using advanced biology and...
-
How Novartis is Changing Cancer Treatment and Putting Patients First in Modern Cancer Care
In this episode of "Rx for Biotech", host Chris Leidli speaks with Rodney Gillespie, Senior Vice President and U.S. Therapeutic Area Head for Oncology at Novartis, about the rapid evolution of prostate cancer care, including the rise of radioligand therapy and PSMA-targeted treatments like...
-
Fixing the Body's Shield: A New Way to Fight Neurodegenerative Diseases
What if helping the immune system find balance could meaningfully slow disease progression for diseases like ALS or Alzheimer’s? In this episode of Rx for Biotech, host Chris Leidli sits down with Arun Swaminathan, CEO of Coya Therapeutics, to talk about a new and hopeful approach to treating...
-
How to Advocate for Yourself in Cancer Care: Insights from a Top Oncologist
A cancer diagnosis can feel overwhelming - but patients are not powerless. In this episode, Dr. Nainesh Parikh of Moffitt Cancer Center explains how patients and families can better advocate for themselves, navigate complex healthcare systems, and get connected to the right care at the right time.
-
A New Hope for Skin Cancer: The Story Behind a Promising Immunotherapy
This episode is about hope, and about a different way of thinking about cancer treatment. My guest is Dr. Øystein Rekdal, CEO and co-founder of Lytix Biopharma. Øystein is a scientist and leader who has spent decades studying how the immune system works - and how it can be helped to recognize and...
-
Targeting the Fire Within: How InflaRx Is Redefining Inflammation Control
InflaRx CEO Dr. Niels Riedmann joins Rx for Biotech to discuss how the company is pioneering complement-directed therapies to control severe inflammation and autoimmune disease. We break down the science behind INF904, and why C5a is such a powerful immune driver, and how precision immunology is...
-
How Novel Genetic Medicines may improve treatment of chronic Neurological Diseases
In this episode of Rx for Biotech podcast, I speak with Philippe Chambon MD, PhD, CEO of EG 427, about how his company's HERMES technology platform could improve on the precision, durability and safety of gene therapy delivery. EG 427's lead candidate, EG110A, targets neurogenic bladder - a…
more -
Restoring Breath: Biologic Innovation for the Most Vulenerable Patients
Airway Therapeutics is taking on one of the toughest challenges in medicine - helping premature infants breathe on their own. In this episode of Rx for Biotech, CEO Marc Salzberg shares how zelpultide alfa, an investigational, first-in-class biologic, could transform care for newborns with...
-
Reprogramming Immunity: How CCR5 Blockade Could Redefine Cancer Therapy
In this podcast episode, Dr. Jay Lalezari, CEO of CytoDyn Therapeutics, discusses the company's progress in developing a novel immunotherapy that targets the CCR5 receptor, one of the master immune cell regulators. Jay reviews some of the early clinical data with leronlimab, a first-in-class...
-
The Alpha Edge: Perspective Therapeutics on the Future of Theranostics and Radiopharmaceutical Therapies
In this episode of Tc for Biotech, host Chris Leidli sits down with Thijs Spoor, CEO of Perspective Therapeutics, to unpack the future of radiopharmaceuticals for the treatment of cancer. This conversation goes beyond the science to explore the infrastructure and strategy that determines success…
more -
Harnessing the Immune System: PDS Biotech’s NextGen Approach to Cancer Treatment
In this episode of Rx for Biotech, host Chris Leidli sits down with Dr. Frank Bedu-Addo, CEO of PDS Biotechnology, to discuss how the company is reimagining immunotherapy with its proprietary Versamune® T-cell activating platform.
-
How Nonacus is Changing Cancer Detection with CEO, Jeff Bousfield
Early cancer detection doesn't have to mean invasive tests. In this podcast episode, we sit down with Jeff Bousfield, CEO of Nonacus Cancer Diagnostics, to explore how his UK-based company is revolutionizing precision cancer diagnostics with a powerful suite of non-invasive tools. Jeff shares the...
-
Hope in Hard Places: A Potential New Option for Patients with Pancreatic Cancer
Metastatic pancreatic cancer remains one of the deadliest cancers, but a new approach is taking shape - and it's showing promise in early clinical studies. In this episode, Dan Schmitt, President and CEO of Actuate Therapeutics, shares how elraglusib, an investigational targeted therapy, may...
-
How Mesenchymal Stem Cells Are Shaping the Future of Medicine with Dr. Kilian Kelly
In this podcast episode, Dr. Kilian Kelly, CEO of Cynata Therapeutics, discusses the future of regenerative medicine! Discover how mesenchymal stem cells (MSCs)—powerful cells that repair and regenerate tissues—are revolutionizing treatments for a range of diseases. Dr. Kelly shares insights on...
-
Patient Perspective with CAR-T Cell Therapy Advocate, Brad Watt
Our guest in this podcast episode is lymphoma survivor and CAR-T cell therapy patient advocate, Brad Watts. In this episode, Brad shares his personal story battling lymphoma at the young age of 29 along with his experience receiving an innovative cell therapy. This field is transforming lives and...
-
How AI is Transforming Job Search and Recruiting in Life Sciences and Technology
AI is transforming job search, recruiting and hiring practices. Our guest in this podcast episode is Steve Swan, Practice Leader at The Swan Group. Steve is an Executive Recruiter specializing in technology for the Pharmaceutical and Biotech Industry. In this episode Steve shares his insights on...
-
From Nigeria to the USA: Gene Therapy Journey with Sickle Cell Warrior, Jimi Olaghere
Gene therapy offers significant hope for treating sickle cell disease (SCD), a genetic disorder caused by a single mutation in the hemoglobin gene. Recent advancements have led to promising developments and FDA approvals, but challenges remain. In this podcast episode, gene therapy survivor, Jimi...
-
The Promise of Dendritic Cell Vaccines with Diakonos Oncology President and COO Jay Hartenbach
In this podcast episode, hear from Diakonos Oncology President and Chief Operating Officer Jay Hartenbach, who provides an update on the company's innovative dendritic cell vaccine therapy designed to tackle some of the most challenging cancers, including glioblastoma and pancreatic cancer
-
New Therapies for Brain Cancer with Neurosurgeon Thomas Chen, CEO of NeOnc
Dr. Thomas Chen is a world-renowned neurosurgeon, Director of Surgical Neuro-Oncology at the University of Southern California, and the founder and CEO of NeOnc Technologies. In this podcast episode we discuss the company’s unique approach to treating glioblastoma and other aggressive brain cancers.
-
From Meditation to Music: Exploring AI's Boundless Potential with Sreekanth Gopi
Our guest in this podcast episode is Sreekanth Gopi, a leader in generative AI and machine learning. Sreekanth has applied AI to fields as diverse as physiological monitoring, meditation, and even generating multi-track Indian classical music. He’s published award-winning research on EEG spectral...
-
How Arvinas is Transforming Cancer and Neuroscience Therapies: An Interview with CBO, Randy Teel, PhD
Arvinas is a biotech company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases. In this podcast episode, Dr. Randy Teel discusses the company's PROTAC protein degrader technology platform and its pipeline of clinical-stage assets, with a focus…
more -
The Future of Healthcare: Insights from the Biggest Health Tech Conference of 2024
HLTH brings together all the ecosystem stakeholders each year to discuss the innovations that will help solve some of healthcare's biggest challenges. In this podcast episode, Noe Gutierrez, the Head of Commercial Operations at Genoplex, Inc., shares many of the key themes and insights from the...
-
How NGGT is Pioneering the Next Wave of Gene Therapies
Next Generation Gene Therapies is developing novel gene therapies for the treatment of many rare diseases. In this podcast episode, the company's Co-Founder and Chief Operating Officer, Guang Qu, discusses how the company's dual-functional vector tech platform is being used to target many diseases.
-
Unlocking the Power of IL-2 with Aulos CEO, Aron Knickerbocker
Immunotherapies continue to redefine treatment for many types of cancer and one of the first immunotherapies approved and used clinically as a therapeutic is Interleukin-2, or IL-2. Aulos Bioscience is an immuno-oncology company that has developed AU-007, a potential best-in-class IL-2, that...
-
Left Behind: Addressing Health Equity for the Rare Disease Patient Community
In this podcast episode, we discuss the importance of addressing health equity for the rare disease community with Tamar Thompson, Head of Corporate Affairs at Alexion, AstraZeneca Rare Disease. Tamar discussed her efforts to champion health policy, advocacy, equity, and awareness for rare...
-
Emerging Cell Therapies for Blood Cancers with Arcellx CMO, Chris Heery, MD
In this podcast episode, we sit down with Christopher Heery, the Chief Medical Officer at Arcellx to learn about the company's pipeline and lead cell therapy, anitocabtagene autoleucel, or anito-cel, that is in development for multiple myeloma. Multiple myeloma, like lymphoma and leukemia are…
more -
Unlocking AI In Oncology with James Zou, PhD
In this podcast episode, Dr. James Zou, Associate Professor of Biomedical Data Science and Faculty DIrector of the AI for Health department at Stanford University, shares current use cases for AI in healthcare and oncology and discusses how we can overcome challenges with LLMs to unlock the full...
-
Revolutioning Patient Access: An Interview with Genoplex CTO, Shoukri Kattan
In this episode, Genoplex Founder and CEO, Chris Leidli, and CTO, Shoukri Kattan, take a dive deep into their shared passion for health, wellness, and longevity, and explore how technology is revolutionizing patient access to advanced therapies. Chris and Shoukri discuss the groundbreaking work...
-
Building a Leading Cell Therapy Service Line with Robb Richards - Penn Medicine
Our guest for this podcast episode is Robb Richards, Corporate Director of Cell Therapy and Transplant at University of Pennsylvania, Penn Medicine. In this episode, we discuss how Penn Medicine is working to improve patient access to cellular therapies and how technology has evolved to…
more -
How MedStack helps Health Tech companies with Compliance and Data Privacy
Our guest for this episode is Balaji Gopalan, CEO and Co-Founder of MedStack where we discuss how MedStack's tech stack is enabling digital health start-ups to be healthcare data compliant. MedStack streamlines compliance with out-of-the-box HIPAA controls and ready-to-use privacy policies,...
-
How NervGen is Developing Novel Treatments to Repair Damage to the Nervous System
Our guest for this podcast episode is Mike Kelly, President & CEO of NervGen Pharma. NervGen is a clinical-stage biotech company at the forefront of developing treatments that empower the nervous system to repair itself following damage from injury or disease.
-
ASCO 2024 Recap, ADCs, Cell Therapies and RLTs
In this podcast episode, your host, Chris Leidli, MS, MBA, goes beyond the ASCO 2024 headlines and puts a spotlight on the new clinical data for advanced therapies you don't want to miss.
-
ASGCT 2024 Abstracts Preview
In this episode, we preview the top American Society of Gene and Cell Therapy (ASGCT) 2024 annual meeting abstracts with guests Dr. Emily Walsh Martin from Tremont Therapeutics Consulting and Lynnea Olivarez, Incoming Chair of the ASGCT Communications Committee.
-
Update on Evolving Tech and Data Standards to Improve Cell Therapy Informatics
Over the years, electronic health records (EHRs) have revolutionized medical practice, digitizing patient data and streamlining care. But the current systems are not well suited to support collection of real-world data or the tracking of longitudinal outcomes across patient populations. This is...
-
How Ryght is Building a Generative AI Platform for BioPharma
Our guest for this podcast episode is Simon Arkell, CEO of Ryght. Ryght is developing the next generation of safe and secure generative AI to empower Life Science companies to ingest real-time data and make actionable knowledge directly available to discovery, clinical, and commercial teams.
-
Revolutionizing Genetic Counseling: A Conversation with Igentify CEO, Doron Behar
Our guest for this podcast episode is Doron Behar, MD, PhD, co-founder and CEO of Igentify, a digital health, artificial intelligence and genetic counseling company. In this episode, Dr. Behar shares how his company has developed a medical-grade tech platform that optimizes genomic workflows and...
We're indexing this podcast's transcripts for the first time — this can take a minute or two. We'll show results as soon as they're ready.
No matches for "" in this podcast's transcripts.
No topics indexed yet for this podcast.
Loading reviews...
ABOUT THIS SHOW
"Rx for Biotech" is a healthcare education podcast dedicated to helping patients, caregivers, and healthcare professionals understand the rapidly evolving world of advanced therapies - and how patients can access them. From cell therapies and gene therapies to radiopharmaceuticals, immunotherapies, and next-generation treatments for cancer and autoimmune disease, this channel bridges the gap between breakthrough science and real-world patient care. Hosted by Chris Leidli, founder of Genoplex and longtime host of the Rx for Biotech podcast, each episode features conversations with:• Biotech and pharmaceutical CEOs• Physician leaders and researchers• AI and tech leaders building tools to improve healthcare access• Innovators building the next generation of personalized therapiesAbout Therapy4me.aiTherapy4me.ai is a consumer education and care-navigation platform designed to help patients find and connect with specialists at treatment centers offering personalized medicines and ad
HOSTED BY
Podcast Host Chris Leidli
CATEGORIES
Loading similar podcasts...
Frequently Asked Questions
How many episodes does Rx for Biotech have?
Rx for Biotech currently has 95 episodes available on PodParley. New episodes are automatically indexed when they're published to the podcast feed.
What is Rx for Biotech about?
"Rx for Biotech" is a healthcare education podcast dedicated to helping patients, caregivers, and healthcare professionals understand the rapidly evolving world of advanced therapies - and how patients can access them. From cell therapies and gene therapies to radiopharmaceuticals, immunotherapies,...
How often does Rx for Biotech release new episodes?
Rx for Biotech has 95 episodes. Check the episode list to see recent publication dates and frequency.
Where can I listen to Rx for Biotech?
You can listen to Rx for Biotech on PodParley by clicking any episode. We provide an embedded audio player for direct listening, and you can also subscribe via your preferred podcast app using the RSS feed.
Who hosts Rx for Biotech?
Rx for Biotech is created and hosted by Podcast Host Chris Leidli.
URL copied to clipboard!